A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says

Health
By Pam Belluck from NYT Health https://ift.tt/Fak0ROx
via IFTTT Clinical Trials, Drugs (Pharmaceuticals), Amyotrophic Lateral Sclerosis, Corporations, Suits and Litigation (Civil), Brain, your-feed-science, your-feed-healthcare Results of a large clinical trial found the treatment did not work any better than a placebo.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda